Freestone Capital Holdings LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Freestone Capital Holdings LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% during the fourth quarter, HoldingsChannel reports. The firm owned 7,535 shares of the medical equipment provider’s stock after acquiring an additional 72 shares during the period. Freestone Capital Holdings LLC’s holdings in Intuitive Surgical were worth $3,933,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ISRG. Bennett Selby Investments LP boosted its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC lifted its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares in the last quarter. LVW Advisors LLC lifted its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC lifted its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,598 shares of company stock worth $7,223,467. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $568.02 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s 50 day simple moving average is $571.70 and its two-hundred day simple moving average is $530.90. The company has a market cap of $202.32 billion, a price-to-earnings ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective for the company. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.